Showing results (2041-2050 of 2,171) with videos related to
Sort By:
Pageof 218
Arteriosclerosis, Thrombosis, and Vascular Biology|February 2, 2023
Macrophage Galactose Lectin Contributes to the Regulation of FVIII (Factor VIII) Clearance in Mice-Brief ReportSoracha E Ward, Thomas Guest, Ciara Byrne, et al.Stem Cell Reports|February 24, 2023
Granulin loss of function in human mature brain organoids implicates astrocytes in TDP-43 pathologyMartina de Majo, Mark Koontz, Elise Marsan, et al.CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 9, 2026
Increasing the environmental sustainability of operating rooms in Canada: an evidence-informed guideline for policyJamie Goldman, Emily A Pearsall, Kathy Liu, et al.Prehospital Emergency Care|January 21, 2026
Establishing Quality Measures for the Prehospital Pediatric Readiness ProjectCaleb E Ward, Kathleen Adelgais, Rachael Alter, et al.Journal of Biomolecular Screening|May 10, 2008
Use of cryopreserved cells for enabling greater flexibility in compound profilingM J Wigglesworth, K J Lawless, D J Standing, et al.Journal of Thrombosis and Haemostasis : JTH|May 30, 2021
ADAMTS13 regulation of VWF multimer distribution in severe COVID-19Soracha E Ward, Helen Fogarty, Ellie Karampini, et al.Clinical and Experimental Immunology|April 24, 2023
SARS-CoV-2 infection is associated with anti-desmoglein 2 autoantibody detectionKerensa E Ward, Lora Steadman, Abid R Karim, et al.American Journal of Pharmaceutical Education|January 25, 2024
An Integrative Review of Micro-Credentials and Digital Badges for Pharmacy EducatorsSarah E Vordenberg, Nicholas M Fusco, Kristina E Ward, et al.Human Molecular Genetics|September 25, 1997
A novel phenotypic pattern in X-linked inheritance: craniofrontonasal syndrome maps to Xp22G J Feldman, D E Ward, E Lajeunie-Renier, et al.Journal of Medicinal Chemistry|November 9, 2010
Discovery of 1-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone (GSK163090), a Potent, selective, and orally active 5-HT1A/B/D receptor antagonistColin P Leslie, Matteo Biagetti, Silvia Bison, et al.Pageof 218